Does CARVEDILOL Cause Supraventricular tachycardia? 66 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Supraventricular tachycardia have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 0.5% of all adverse event reports for CARVEDILOL.
66
Reports of Supraventricular tachycardia with CARVEDILOL
0.5%
of all CARVEDILOL reports
10
Deaths
62
Hospitalizations
How Dangerous Is Supraventricular tachycardia From CARVEDILOL?
Of the 66 reports, 10 (15.2%) resulted in death, 62 (93.9%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does CARVEDILOL Cause?
Hypotension (1,822)
Dyspnoea (1,143)
Dizziness (1,138)
Drug ineffective (1,102)
Fatigue (1,020)
Completed suicide (1,019)
Bradycardia (861)
Toxicity to various agents (690)
Cardiac failure (636)
Asthenia (562)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
METOPROLOL (132)
ROSIGLITAZONE (114)
TREPROSTINIL (113)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
Which CARVEDILOL Alternatives Have Lower Supraventricular tachycardia Risk?
CARVEDILOL vs CASIMERSEN
CARVEDILOL vs CASIRIVIMAB
CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB
CARVEDILOL vs CASPOFUNGIN
CARVEDILOL vs CATEQUENTINIB